The co-delivery of a low-dose P-glycoprotein inhibitor with doxorubicin sterically stabilized liposomes against breast cancer with low P-glycoprotein expression
Wei Gao,1 Zhiqiang Lin,1 Meiwan Chen,2 Xiucong Yang,1 Zheng Cui,1 Xiaofei Zhang,1 Lan Yuan,3 Qiang Zhang11State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 2State Key Laboratory of Quality Research in Chinese Medicine, Inst...
Guardado en:
Autores principales: | Gao W, Lin Z, Chen M, Yang X, Cui Z, Zhang X, Yuan L, Zhang Q |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5a6c244b6af4481891fd44023cc6a07e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Herpes Simplex Virus Glycoprotein C Regulates Low-pH Entry
por: Tri Komala Sari, et al.
Publicado: (2020) -
P-glycoprotein and chronic rhinosinusitis
por: Marcel M. Miyake, et al.
Publicado: (2018) -
The combined use of paclitaxel-loaded nanoparticles with a low-molecular-weight copolymer inhibitor of P-glycoprotein to overcome drug resistance
por: Wan CP, et al.
Publicado: (2013) -
Serum amyloid P is a sialylated glycoprotein inhibitor of influenza A viruses.
por: Emma R Job, et al.
Publicado: (2013) -
The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation
por: Yu KF, et al.
Publicado: (2013)